Cancer Immunotherapy Guidelines Melanoma Subcommittee

SITC Cancer Immunotherapy Guidelines are a collection of consensus statements developed by experts in the treatment of specific types of cancer. Each consensus statement provides key indicators to help practicing oncologists determine when and how to best use immunotherapy to treat their patients. These systematically developed recommendations promote enhanced clinical decisions concerning patient selection, toxicity management, clinical endpoints, and the sequencing or combination of therapies. The Melanoma Task Force was developed to generate a consensus statement specifically for skin cancer.

Chair

Ryan J. Sullivan, MD
Massachusetts General Hospital

Co-Chair

Anna C. Pavlick, DO, MBA
New York University Cancer Institute

Current Members
1 Member